Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Saline Solution × 30 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Pain, Postoperative 1

Interventions

Capecitabine 3 Oxaliplatin 2 Bevacizumab 2 trastuzumab deruxtecan 1 tislelizumab 1 spartalizumab 1 pembrolizumab 1 durvalumab 1 defactinib 1 decitabine and cedazuridine drug combination 1 dalpiciclib 1 cedazuridine 1 bemarituzumab 1 atezolizumab 1 anlotinib 1 Vitamin D 1 Synbiotics 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Saline Solution 1 Radiotherapy 1 Radiosurgery 1 Prebiotics 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Olanzapine 1 Nivolumab 1 Mastectomy 1 Magnesium Sulfate 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07445451 2026-03-03

TURBT

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Phase NA Completed

Urinary Bladder Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡